Pages that link to "Bcr-Abl tyrosine-kinase inhibitor"
Appearance
Showing 33 items.
- Cancer (links | edit)
- Philadelphia chromosome (links | edit)
- Chronic myelogenous leukemia (links | edit)
- Imatinib (links | edit)
- Drug design (links | edit)
- ABL (gene) (links | edit)
- STAT5 (links | edit)
- Bosutinib (links | edit)
- Tyrosine kinase inhibitor (links | edit)
- Discovery and development of Bcr-Abl tyrosine kinase inhibitors (redirect to section "History") (links | edit)
- NMDA receptor (links | edit)
- Drug discovery (links | edit)
- Drug design (links | edit)
- Preclinical development (links | edit)
- Drug development (links | edit)
- Nilotinib (links | edit)
- Dasatinib (links | edit)
- Hit to lead (links | edit)
- Discovery and development of statins (links | edit)
- Discovery and development of ACE inhibitors (links | edit)
- Bosutinib (links | edit)
- Discovery and development of cyclooxygenase 2 inhibitors (links | edit)
- Discovery and development of angiotensin receptor blockers (links | edit)
- Discovery and development of triptans (links | edit)
- Discovery and development of dipeptidyl peptidase-4 inhibitors (links | edit)
- Discovery and development of non-nucleoside reverse-transcriptase inhibitors (links | edit)
- Discovery and development of HIV-protease inhibitors (links | edit)
- Discovery and development of TRPV1 antagonists (links | edit)
- Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors (links | edit)
- Melatonin receptor agonist (links | edit)
- Discovery and development of proton pump inhibitors (links | edit)
- Discovery and development of antiandrogens (links | edit)
- Discovery and development of cephalosporins (links | edit)
- Discovery and development of integrase inhibitors (links | edit)
- C-Met inhibitor (links | edit)
- Phases of clinical research (links | edit)
- 5-HT2C receptor agonist (links | edit)
- Discovery and development of direct thrombin inhibitors (links | edit)
- MTOR inhibitors (links | edit)
- Discovery and development of phosphodiesterase 5 inhibitors (links | edit)
- Discovery and development of beta-blockers (links | edit)
- GABAA receptor positive allosteric modulator (links | edit)
- Cereblon E3 ligase modulator (links | edit)
- Development and discovery of SSRI drugs (links | edit)
- Discovery and development of gliflozins (links | edit)
- Discovery and development of neuraminidase inhibitors (links | edit)
- Discovery and development of beta2 agonists (links | edit)
- Discovery and development of gastrointestinal lipase inhibitors (links | edit)
- Discovery and development of direct Xa inhibitors (links | edit)
- Discovery and development of NS5A inhibitors (links | edit)
- Discovery and development of 5α-reductase inhibitors (links | edit)
- Talk:Bcr-Abl tyrosine-kinase inhibitor (links | edit)
- User:AlexNewArtBot/StatisticsSearchResult/archive1 (links | edit)
- User:AlexNewArtBot/GeneticsSearchResult/archive2 (links | edit)
- User:AlexNewArtBot/ChemistrySearchResult/archive22 (links | edit)
- User:AlexNewArtBot/MolCellBiolSearchResult/archive3 (links | edit)
- User:AlexNewArtBot/CleanupSearchResult/archive49 (links | edit)
- User:Hópur 5 (links | edit)
- User:AlexNewArtBot/MedicineSearchResult/archive31 (links | edit)
- User:AlexNewArtBot/PhysicsSearchResult/archive13 (links | edit)
- User:AlexNewArtBot/GoodSearchResult/archive79 (links | edit)
- User:AlexNewArtBot/TestFeedSearchResult/archive139 (links | edit)
- User:HlynurT/Discovery and development of thalidomide and its analogs (links | edit)
- User:Hopur2bdk/Direct thrombin inhibitors, drug discovery and development (links | edit)
- User:Lybbar12/Drug discovery and development of mTOR inhibitors (links | edit)
- User:Mogsan1/sandbox (links | edit)
- Template:Drug design (links | edit)
- Bcr-Abl tyrosine kinase inhibitors (redirect page) (links | edit)
- Bcr-Abl tyrosine kinase inhibitor (redirect page) (links | edit)
- Discovery and development of Bcr-Abl tyrosine-kinase inhibitors (redirect page) (links | edit)
- Second generation CML drugs (redirect to section "Second generation drugs") (links | edit)
- Ponatinib (links | edit)
- T315i (redirect to section "-T315I mutation") (links | edit)
- Radotinib (links | edit)
- Bcr-Abl inhibitor (redirect page) (links | edit)
- Bcr-abl inhibitor (redirect page) (links | edit)
- Saracatinib (links | edit)
- Bafetinib (links | edit)
- Rebastinib (redirect to section "Others") (links | edit)
- Dehydroepiandrosterone (links | edit)
- Growth factor (links | edit)
- Insulin (links | edit)
- Insulin-like growth factor (links | edit)
- Integrin (links | edit)
- Testosterone (links | edit)
- Tyrosine kinase (links | edit)
- Erythropoietin (links | edit)
- Dexamethasone (links | edit)
- Thrombopoietin (links | edit)
- Imatinib (links | edit)
- Filgrastim (links | edit)
- Amitriptyline (links | edit)
- Brain-derived neurotrophic factor (links | edit)
- Trastuzumab (links | edit)
- Insulin-like growth factor 1 (links | edit)
- Adult neurogenesis (links | edit)
- Gefitinib (links | edit)
- Platelet-derived growth factor (links | edit)
- Neurotrophin (links | edit)
- Wnt signaling pathway (links | edit)
- Transforming growth factor (links | edit)
- Epidermal growth factor (links | edit)
- Bevacizumab (links | edit)
- Cetuximab (links | edit)
- Vascular endothelial growth factor (links | edit)
- Epidermal growth factor receptor (links | edit)
- Glucose-6-phosphate isomerase (links | edit)
- Neuregulin (links | edit)
- Fibroblast growth factor 2 (links | edit)
- Amphiregulin (links | edit)
- Nerve growth factor (links | edit)
- Pegfilgrastim (links | edit)
- Erlotinib (links | edit)
- Insulin-like growth factor 2 (links | edit)
- Hepatocyte growth factor receptor (links | edit)
- Prasterone (links | edit)
- HER2 (links | edit)
- Palifermin (links | edit)
- Sorafenib (links | edit)
- Colony-stimulating factor (links | edit)
- Sunitinib (links | edit)
- K252a (links | edit)
- Fibroblast growth factor (links | edit)
- Fibroblast growth factor 1 (links | edit)
- FGF3 (links | edit)
- Hemopoietic growth factor (links | edit)
- Lapatinib (links | edit)
- Pleiotrophin (links | edit)
- Glial cell line-derived neurotrophic factor (links | edit)
- Oncomodulin (links | edit)
- Sargramostim (links | edit)
- Tropomyosin receptor kinase A (links | edit)
- Tropomyosin receptor kinase B (links | edit)
- Low-affinity nerve growth factor receptor (links | edit)
- Tropomyosin receptor kinase C (links | edit)
- Fibroblast growth factor 23 (links | edit)
- Insulin-like growth factor 1 receptor (links | edit)
- Dehydroepiandrosterone sulfate (links | edit)
- Neurotrophic factors (links | edit)
- Receptor tyrosine kinase (links | edit)
- Ephrin receptor (links | edit)
- Neurotrophin-3 (links | edit)
- Angiopoietin (links | edit)
- Erythropoietin receptor (links | edit)
- Somatomedin receptor (links | edit)
- Platelet-derived growth factor receptor (links | edit)
- Fibroblast growth factor receptor (links | edit)
- Neurturin (links | edit)
- Nilotinib (links | edit)
- Dasatinib (links | edit)
- Ranibizumab (links | edit)
- Ciliary neurotrophic factor (links | edit)
- Hepatocyte growth factor (links | edit)
- Glia maturation factor (links | edit)
- Panitumumab (links | edit)
- Vandetanib (links | edit)
- Midkine (links | edit)
- Pituitary adenylate cyclase-activating peptide (links | edit)
- Adrenomedullin (links | edit)
- Pegaptanib (links | edit)
- Insulin-like growth factor-binding protein (links | edit)
- CTGF (links | edit)
- Pertuzumab (links | edit)
- Ertumaxomab (links | edit)
- KIT (gene) (links | edit)
- TGF alpha (links | edit)
- Neurotrophin-4 (links | edit)
- Matuzumab (links | edit)
- Nimotuzumab (links | edit)
- Zalutumumab (links | edit)
- Semaxanib (links | edit)
- Fibroblast growth factor receptor 2 (links | edit)
- Insulin-like growth factor 2 receptor (links | edit)
- Keratinocyte growth factor (links | edit)
- Cediranib (links | edit)
- VEGF receptor (links | edit)
- Persephin (links | edit)
- Artemin (links | edit)
- GDNF family of ligands (links | edit)
- Angiopoietin receptor (links | edit)
- Angiopoietin 1 (links | edit)
- ANGPT2 (links | edit)
- RET proto-oncogene (links | edit)
- Stem cell factor (links | edit)
- Receptor activity-modifying protein (links | edit)
- RAMP1 (links | edit)
- RAMP2 (links | edit)
- RAMP3 (links | edit)
- Mecasermin rinfabate (links | edit)
- N-Acetylserotonin (links | edit)
- Neuregulin 1 (links | edit)
- Ancestim (links | edit)
- Fibroblast growth factor receptor 1 (links | edit)
- Fibroblast growth factor receptor 3 (links | edit)
- Pazopanib (links | edit)
- Growth factor receptor (links | edit)
- ErbB (links | edit)
- Heparin-binding EGF-like growth factor (links | edit)
- Epiregulin (links | edit)
- Epigen (links | edit)
- Betacellulin (links | edit)
- Ephrin (links | edit)
- FMS-like tyrosine kinase 3 ligand (links | edit)
- Becaplermin (links | edit)
- PDGFRB (links | edit)
- IGFBP3 (links | edit)
- Kinase insert domain receptor (links | edit)
- ERBB3 (links | edit)
- ERBB4 (links | edit)
- IGFBP2 (links | edit)
- IGFBP5 (links | edit)
- Fibroblast growth factor receptor 4 (links | edit)
- Ephrin B2 (links | edit)
- IGFBP4 (links | edit)
- PDGFA (links | edit)
- CALCRL (links | edit)
- Ephrin B1 (links | edit)
- ADCYAP1R1 (links | edit)
- GFRA1 (links | edit)
- Lenograstim (links | edit)
- Molgramostim (links | edit)
- PDGFB (links | edit)
- Vascular endothelial growth factor C (links | edit)
- IGFBP6 (links | edit)
- EPH receptor B2 (links | edit)
- Trk receptor (links | edit)
- EPH receptor A2 (links | edit)
- Axitinib (links | edit)
- IGFBP1 (links | edit)
- FGF7 (links | edit)
- Placental growth factor (links | edit)
- EPH receptor B4 (links | edit)
- Thrombopoietin receptor (links | edit)
- Ephrin A1 (links | edit)
- MST1R (links | edit)
- EPH receptor A4 (links | edit)
- EPH receptor B1 (links | edit)
- IGFBP7 (links | edit)
- FGF10 (links | edit)
- C-fos-induced growth factor (links | edit)
- EPH receptor A3 (links | edit)
- Fibroblast growth factor 8 (links | edit)
- EPHB6 (links | edit)
- EPHA8 (links | edit)
- EPHA7 (links | edit)
- FGF9 (links | edit)
- EPH receptor A5 (links | edit)
- Hepatoma-derived growth factor (links | edit)
- Ephrin A4 (links | edit)
- FGF4 (links | edit)
- FGF5 (links | edit)
- MST1 (links | edit)
- Ephrin A2 (links | edit)
- Ephrin A3 (links | edit)
- Ephrin B3 (links | edit)
- EPH receptor A1 (links | edit)
- EPHB3 (links | edit)
- FGF18 (links | edit)
- Proteoglycan 4 (links | edit)
- PDGFC (links | edit)
- FGF19 (links | edit)
- EPHA6 (links | edit)
- Vascular endothelial growth factor B (links | edit)
- PDGFD (links | edit)
- FGF14 (links | edit)
- ANGPT4 (links | edit)
- Fibroblast growth factor receptor-like 1 (links | edit)
- FGF13 (links | edit)
- GFRA3 (links | edit)
- FGF6 (links | edit)
- FGF12 (links | edit)
- GFRA2 (gene) (links | edit)
- Neuregulin 2 (links | edit)
- FGF17 (links | edit)
- Vascular endothelial growth factor A (links | edit)
- Ciliary neurotrophic factor receptor (links | edit)
- Platelet-derived growth factor receptor A (links | edit)
- Lestaurtinib (links | edit)
- CSPG5 (links | edit)
- Fibroblast growth factor 21 (links | edit)
- Mecasermin (links | edit)
- Ponazuril (links | edit)
- Gossypetin (links | edit)
- Bosutinib (links | edit)
- Neuregulin 3 (links | edit)
- Neuregulin 4 (links | edit)
- Afatinib (links | edit)
- Neurotrophic factor receptor (links | edit)
- FGF11 (links | edit)
- Prasterone sulfate (links | edit)
- FGF16 (links | edit)
- FGF22 (links | edit)
- FGF20 (links | edit)
- Cixutumumab (links | edit)
- Ramucirumab (links | edit)
- Alacizumab pegol (links | edit)
- Tanezumab (links | edit)
- Figitumumab (links | edit)
- Neratinib (links | edit)
- Necitumumab (links | edit)
- Robatumumab (links | edit)
- RTK class III (links | edit)
- Toceranib (links | edit)
- Renalase (links | edit)
- Diosmetin (links | edit)
- Lenvatinib (links | edit)
- Regorafenib (links | edit)
- Grandinin (links | edit)
- Olaratumab (links | edit)
- Mubritinib (links | edit)
- Tyrosine kinase inhibitor (links | edit)
- Crizotinib (links | edit)
- Tivozanib (links | edit)
- Vemurafenib (links | edit)
- Crenolanib (links | edit)
- Quizartinib (links | edit)
- Trastuzumab emtansine (links | edit)
- Motesanib (links | edit)
- Nintedanib (links | edit)
- Cabozantinib (links | edit)
- Ponatinib (links | edit)
- Selumetinib (links | edit)
- Brigatinib (links | edit)
- Foretinib (links | edit)
- Dalotuzumab (links | edit)
- Ficlatuzumab (links | edit)
- Flanvotumab (links | edit)
- Fulranumab (links | edit)
- Ganitumab (links | edit)
- Icrucumab (links | edit)
- Onartuzumab (links | edit)
- Teprotumumab (links | edit)
- Rilotumumab (links | edit)
- Canertinib (links | edit)
- C-Met inhibitor (links | edit)
- Ephrin A5 (links | edit)
- Fasinumab (links | edit)
- Masitinib (links | edit)
- Patritumab (links | edit)
- Nesvacumab (links | edit)
- Linsitinib (links | edit)
- Dusigitumab (links | edit)
- Trametinib (links | edit)
- Dabrafenib (links | edit)
- FGF15 (links | edit)
- FGF15/19 (links | edit)
- EPHA10 (links | edit)
- Imgatuzumab (links | edit)
- Duligotuzumab (links | edit)
- Futuximab (links | edit)
- Tovetumab (links | edit)
- Sprifermin (links | edit)
- Encorafenib (links | edit)
- Norwogonin (links | edit)
- Cobimetinib (links | edit)
- ALTO-100 (links | edit)
- Amitriptyline/perphenazine (links | edit)
- Growth factor receptor inhibitor (links | edit)
- Radotinib (links | edit)
- Icotinib (links | edit)
- Dacomitinib (links | edit)
- Ceritinib (links | edit)
- GFRA4 (links | edit)
- GFRα (links | edit)
- Tropoflavin (links | edit)
- HIOC (links | edit)
- Binimetinib (links | edit)
- Emibetuzumab (links | edit)
- Seribantumab (links | edit)
- Evinacumab (links | edit)
- Cerebrolysin (links | edit)
- IGF-1 LR3 (links | edit)
- Des(1-3)IGF-1 (links | edit)
- T-cell growth factor (links | edit)
- Dihexa (links | edit)
- Tavilermide (links | edit)
- Osimertinib (links | edit)
- Alectinib (links | edit)
- Anti-VEGF (links | edit)
- Deoxygedunin (links | edit)
- ANA-12 (links | edit)
- LM22A-4 (links | edit)
- Cyclotraxin B (links | edit)
- R7 (drug) (links | edit)
- 7,8,3'-Trihydroxyflavone (links | edit)
- Eutropoflavin (links | edit)
- Mirvetuximab soravtansine (links | edit)
- Rociletinib (links | edit)
- Entrectinib (links | edit)
- Brolucizumab (links | edit)
- Capmatinib (links | edit)
- Trofinetide (links | edit)
- Testosterone (medication) (links | edit)
- Tesevatinib (links | edit)
- Prasterone enanthate (links | edit)
- Olmutinib (links | edit)
- Lorlatinib (links | edit)
- Larotrectinib (links | edit)
- Tucatinib (links | edit)
- BNN-20 (links | edit)
- BNN-27 (links | edit)
- Cenegermin (links | edit)
- Murodermin (links | edit)
- Nepidermin (links | edit)
- Trafermin (links | edit)
- Tepotinib (links | edit)
- R13 (drug) (links | edit)
- Faricimab (links | edit)
- Estradiol valerate/prasterone enanthate (links | edit)
- Testosterone propionate/testosterone cypionate/prasterone (links | edit)
- Trastuzumab deruxtecan (links | edit)
- Avapritinib (links | edit)
- Pemigatinib (links | edit)
- Selpercatinib (links | edit)
- Ripretinib (links | edit)
- Pertuzumab/trastuzumab/hyaluronidase (links | edit)
- Lipegfilgrastim (links | edit)
- Trastuzumab/hyaluronidase (links | edit)
- Pralsetinib (links | edit)
- Amivantamab (links | edit)
- Infigratinib (links | edit)
- Asciminib (links | edit)
- Fruquintinib (links | edit)
- Repotrectinib (links | edit)
- Fosgonimeton (links | edit)
- ACD856 (links | edit)
- User:Rich Farmbrough/wanted/drugs (links | edit)
- User:Amyahn95/sandbox (links | edit)
- User:AlphaUniform91/cerebrolysin (links | edit)
- User:I enjoy sandwiches/cerebrolysin (links | edit)
- User:Marbletan/sandbox (links | edit)
- Template:Growth factor receptor modulators (links | edit)
- Olverembatinib (links | edit)
- Talk:Bcr-Abl tyrosine-kinase inhibitor (transclusion) (links | edit)
- User:Fizzelo/sandbox (links | edit)
- User:Nordinem/Books/Semester5 (links | edit)
- User:Kbersbach/Books/cancer (links | edit)
- User:Qwerfjkl/preservedCategories/Category:CS1: long volume value (links | edit)
- User talk:Akrasia25/Archive 5 (links | edit)
- Wikipedia:WikiProject Pharmacology/Lists of pages/Pharmacology articles (links | edit)
- Wikipedia:WikiProject Pharmacology/Lists of pages/Pharmacology all pages (links | edit)
- Wikipedia:WikiProject Pharmacology/Drugbox and WP:PHARM crosscheck (links | edit)
- Wikipedia:CHECKWIKI/WPC 557 dump (links | edit)